Using Enriched Studies For Post-Approval Evidence Needs
Executive Summary
These days, clinical trial sponsors are being asked to provide empirical evidence to many stakeholders with diverse needs and to do so efficiently. By taking a holistic view of post-approval evidence needs, it is possible to address many stakeholders’ needs, thereby minimizing expense while increasing the likelihood of getting data that are fit for a variety of purposes.
You may also be interested in...
Engaging And Retaining Patients In Long-Term Observational Studies
Success of long-term observational research studies depends on retaining participants; patient drop-out can lead to loss of vital data including endpoints. Study design considerations and direct-to-patient engagement strategies can help pharmas improve retention and compliance.
EU Postmarket Efficacy Studies To Get More 'Predictability'
EMA could issue scientific guideline on PAES for public consultation by November.
Hybrid Studies: A Foundation For Comprehensive Evidence Development
Hybrid studies, which integrate prospective and existing health data, can generate evidence of drug and device safety and effectiveness through long-term patient follow-up in real-world settings.